SPIRAPRIL IN TREATMENT OF HEART FAILURE DUE TO DILATED CARDIOMYOPATHY
Abstract
Spirapril in treatment of heart failure due to dilated cardiomyopathy.
About the Authors
T. A. Abdullaev
НИИ кардиологии МЗ республики Узбекистан, Ташкент
Uzbekistan
Uzbekistan
E. V. Kiyakbaeva
НИИ кардиологии МЗ республики Узбекистан, Ташкент
Uzbekistan
Uzbekistan
N. A. Kurbanov
НИИ кардиологии МЗ республики Узбекистан, Ташкент
Uzbekistan
Uzbekistan
I. R. Prohorova
НИИ кардиологии МЗ республики Узбекистан, Ташкент
Uzbekistan
Uzbekistan
R. S. Bekbulatova
НИИ кардиологии МЗ республики Узбекистан, Ташкент
Ukraine
Ukraine
References
1. Амосова Е.Н. Кардиомиопатии. Киев, “Книгаполюс”, 1999.-с.116.
2. Гиляревский С.Р. Новые терапевтические критерии при застойной сердечной недостаточности. Кардиология.; 37: 78-90.
3. Cohn J.N. Critical review of heart failure: the role of left ventricular remodelling in the therapeutic response. Clin. cardiol.; 1995; 18: IV4-IV12.
4. Effects of enalapril on mortality in severe heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N.Engl.J.Med., 1987; 316: 1429-1435.
5. Guitard C., Lohmann W., Alfiero R. et al. Comparison of efficasy of spirapril and enalapril in control of mild-to moderate hypertension. Cardiovascular drugs and therapy, 1997; 11: 449-457.
6. Johnson G., Carson P., Francis G.S., Cohn J.N. for the VheFT VA Cooperative Studies Group. Influence of prerandomization (baseline) variables an mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilatator Therapy on Heart Failure (VheFT II). Circulation, 1993; 87 : VI 32-39.
7. Likoff M.J., Chandler S.L., Kay H.R. Clinical determinants of mortality in chronic congestive heart failure. secondary to idiopathic dilated or to ischemic cardiomyopathy. Am.J.Cardiol., 1987; 59: 634-638.
8. Opasich C., Pinna G.D., Mazza A. et al. Six-minute walking performance in patients with moderate in severe heart failure. Eur.Heart J., 2001; 22: 488-496.
9. Pfeffer J.M., Pfeffer M.A., Braunwald E. Influence of chronic captopril therapy on infarcted left ventricle of the rats. Circ. Res., 1985; 57: 84-95.
10. Rector T.S., Kubo S.H., Cohn J.N. Patients self-assessment of their congestive heart failure. Part 2 content, reliability and validity of a new measure, the Minnesota living with heart failure questionnaire. Heart Failure, 1987; 10: 198-208.
11. Report of the 1995 World Healh Organizations International Society and Federation of Cardiology Task Forse on the definition and classification of cardiomyopathies. Circulation, 1996; 93: 841-2.
12. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N. Engl. J. Med., 1991; 325: 293-302.
Review
For citations:
Abdullaev T.A., Kiyakbaeva E.V., Kurbanov N.A., Prohorova I.R., Bekbulatova R.S. SPIRAPRIL IN TREATMENT OF HEART FAILURE DUE TO DILATED CARDIOMYOPATHY. Russian Journal of Cardiology. 2002;(1):32-34. (In Russ.)
Views:
302
Email this article 